Completed PHASE3 INTERVENTIONAL 4-arm NCT01832636

Intervention and Mechanisms of Alanyl-Glutamine for Inflammation, Nutrition, and Enteropathy (IMAGINE)

Sponsor: Children's Hospital Medical Center, Cincinnati

Conditions Diarrhea Environmental Enteropathy Malnutrition

Updated 5 times since 2017 Last updated: Jul 28, 2016 Started: Oct 31, 2013 Primary completion: Dec 31, 2015 Completion: Dec 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01832636, this PHASE3 trial focuses on Diarrhea and Environmental Enteropathy and remains completed. Sponsored by Children's Hospital Medical Center, Cincinnati, it has been updated 5 times since 2013, reflecting limited change activity. Mental health research at this phase helps define safety and dosing parameters for future study.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Oct 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Children's Hospital Medical Center, Cincinnati
Universidade Federal do Ceara

Data source: Children's Hospital Medical Center, Cincinnati

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Fortaleza, Brazil